QHSLab, Inc.
USAQOTCHealthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $2.1M | $1.4M | $1.2M | $1.4M | $124,532 |
| Operating income | $131,244 | $205,738 | −$240,158 | −$560,539 | −$502,258 | −$275,105 |
| Net income | $457,417 | −$259,239 | −$468,362 | −$996,001 | −$770,176 | −$327,388 |
| Total assets | $2.2M | $1.8M | $1.7M | $2.0M | $2.2M | $297,863 |
| Total liabilities | $546,078 | $2.4M | $2.1M | $1.9M | $1.4M | $906,189 |
| Equity | $1.6M | −$607,756 | −$375,617 | $76,245 | $824,066 | −$608,326 |
| EPS (diluted) | $0.02 | $-0.03 | $-0.05 | $-0.11 | $-0.10 | — |
| Shares out. | 11.3M | 10.2M | 9.3M | 8.8M | 6.8M | 5.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 4.9%
- Net margin
- 17.0%
- Return on equity
- 28.1%
- Return on assets
- 21.1%
- Return on capital (ROCE)
- 7.6%
- Liabilities / assets
- 25.2%
- Debt / equity
- 0.34×
- Book value / share
- $0.14
- Revenue growth (YoY)
- 26.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.02distress
- Accruals / assets
- 12.9%high accruals
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High accruals — earnings-quality risk
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2016
- NT 10-Qmissed a reporting deadline ↗May 16, 2016
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2016
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2015
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Marvin Smollar Family Trust Dtd 2/13/2023Activist (13D)Apr 27, 2026
- Peters Nicholas TerrancePassive (13G)Feb 25, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Apr 30, 2026 | 834 | 1.0 | +100.0% |
| Dec 31, 2025 | 5,305 | 1.0 | -22.8% |
| Dec 15, 2025 | 13,738 | 1.0 | -40.2% |
| Nov 28, 2025 | 22,960 | 1.0 | +100.0% |
| Sep 30, 2025 | 8,900 | 1.0 | +4350.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 26, 2026
- Regulation FD disclosureApr 21, 2026
- Regulation FD disclosureMar 31, 2026
- Regulation FD disclosureJan 26, 2026
- Entered a material agreement · Unregistered equity sale · Other material eventJan 23, 2026
- Regulation FD disclosureJan 16, 2026
- Regulation FD disclosureJan 6, 2026
- Entered a material agreement · Unregistered equity saleJan 2, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KMay 26, 2026
- 10-QMay 14, 2026
- 3PRIMARY DOCUMENTApr 29, 2026
- SCHEDULE 13DApr 27, 2026
- 8-KApr 21, 2026
- 8-KMar 31, 2026
- 10-KMar 30, 2026
- SCHEDULE 13G/AFeb 25, 2026
- SCHEDULE 13GFeb 24, 2026
- 5Feb 13, 2026
- 8-KJan 26, 2026
- 8-KJan 23, 2026
- 8-KJan 16, 2026
- DJan 6, 2026
- 8-KJan 6, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.